Athira Pharma, Inc. (ATHA) Misses Q1 EPS by 5c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q1 EPS of ($0.23), $0.05 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Putin Says His Conversation With Trump Was Very Meaningful - IFX
• Nomura/Instinet Upgrades Singapore Airlines Ltd. (SIA:SP) (SINGF) to Buy
• Bernstein Slashes UnitedHealth Group (UNH) Stock PT, Citing 'Further 2025 Weakness'